Patriot Financial Group Insurance Agency’s Myriad Genetics MYGN Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-400	Closed	-$11K	–	2177
2021 Q4	$11K	Hold	400	–	–	﹤0.01%	1460
2021 Q3	$13K	Hold	400	–	–	﹤0.01%	1367
2021 Q2	$12K	Hold	400	–	–	﹤0.01%	1376
2021 Q1	$12K	Hold	400	–	–	﹤0.01%	1297
2020 Q4	$8K	Buy	+400	New	+$6.46K	﹤0.01%	1299
2019 Q2	–	Sell	-8	Closed	–	–	1456
2019 Q1	$0	Hold	8	–	–	﹤0.01%	1283
2018 Q4	$0	Buy	+8	New	+$288	﹤0.01%	1074

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Patriot Financial Group Insurance Agency's MYGN Position: Q1 2022 in Review

Patriot Financial Group Insurance Agency sold out of Myriad Genetics (MYGN) in Q1 2022, closing a stake of 400 shares — an estimated $11K sold.

Patriot Financial Group Insurance Agency first reported a position in MYGN in Q4 2018 and held it in 7 quarters. The position peaked at $13K in Q3 2021. 205 funds tracked by Wall St. Rank hold MYGN as of Q1 2022.

Patriot Financial Group Insurance Agency reported no remaining Myriad Genetics position as of Q1 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 400 Myriad Genetics shares in Q1 2022, an estimated $11K.
Patriot Financial Group Insurance Agency first reported a position in Myriad Genetics in Q4 2018 and held it in 7 quarters.
Patriot Financial Group Insurance Agency's Myriad Genetics position peaked at $13K in Q3 2021.
205 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2022, filed 11 May 2022.